More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in parallel in taking comprehensive action against drug-resistant infections – socalled ‘superbugs’ – with a joint declaration launched today at the World Economic Forum in Davos, Switzerland.
The statement sets out for the first time how governments and industry need to work together to support sustained investment in the new products needed to beat the challenges of rising drug resistance.
During Florence 2017 Congress which will be held next October, the scientific committee will highlight the recent advances, mechanistic and strategies to develop new tools for treatment of many infectious diseases. Phage Therapy 2017 will provide a unique and cutting edge conference to discuss strategies and challenges of all phagotherapy related fields.
Stakeholders from the academic, regulatory and industrial sectors will be gathered to discuss many hot topics related to this hot topic.
For more information about the calls, please click here.